GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (LTS:0JXZ) » Definitions » Total Stockholders Equity

Galapagos NV (LTS:0JXZ) Total Stockholders Equity : €2,862.6 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Galapagos NV Total Stockholders Equity?

Galapagos NV's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €2,862.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Galapagos NV's Book Value per Share for the quarter that ended in Sep. 2024 was €43.44. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Galapagos NV's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.00.


Galapagos NV Total Stockholders Equity Historical Data

The historical data trend for Galapagos NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Total Stockholders Equity Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,875.66 2,670.36 2,643.36 2,526.03 2,795.57

Galapagos NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,621.56 2,795.57 2,895.01 2,910.30 2,862.57

Galapagos NV  (LTS:0JXZ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Galapagos NV's Book Value per Share for the quarter that ended in Sep. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Galapagos NV's Debt-to-Equity for the quarter that ended in Sep. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galapagos NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV Business Description

Industry
Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Galapagos NV Headlines

No Headlines